Davenport & Co’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-82,200
| Closed | -$1.15M | – | 655 |
|
|
2016
Q3 | $1.15M | Hold |
82,200
| – | – | 0.02% | 273 |
|
|
2016
Q2 | $577K | Buy |
82,200
+2,600
| +3% | +$18.3K | 0.01% | 374 |
|
|
2016
Q1 | $513K | Buy |
79,600
+1,100
| +1% | +$7.08K | 0.01% | 372 |
|
|
2015
Q4 | $2.54M | Sell |
78,500
-17,700
| -18% | -$573K | 0.04% | 181 |
|
|
2015
Q3 | $2.57M | Buy |
96,200
+30,747
| +47% | +$821K | 0.04% | 180 |
|
|
2015
Q2 | $3.15M | Buy |
65,453
+500
| +0.8% | +$24.1K | 0.05% | 179 |
|
|
2015
Q1 | $3.95M | Buy |
64,953
+18,853
| +41% | +$1.15M | 0.06% | 169 |
|
|
2014
Q4 | $2.39M | Hold |
46,100
| – | – | 0.04% | 199 |
|
|
2014
Q3 | $2.03M | Buy |
46,100
+31,100
| +207% | +$1.37M | 0.04% | 209 |
|
|
2014
Q2 | $392K | Buy |
+15,000
| New | +$392K | 0.01% | 412 |
|